


TALLC Corporation Revenue
Pharmaceutical Manufacturing • Laval, Quebec, Canada • 1-10 Employees
TALLC Corporation revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at TALLC Corporation
Robert Zalega
Associate Director
Company overview
| Headquarters | 500 Boulevard Cartier O, Laval, Quebec H7V 5B7, CA |
| Phone number | +15148833447 |
| Website | |
| NAICS | 3254 |
| Keywords | Nanotechnology, Ophthalmology, Inflammation, Dry Eye, Keratoconus, Surgical Pain |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
About TALLC Corporation
TALLC is an emerging ophthalmic medicines company focused on the unmet needs of patients with Progressive Kerotoconus. TALLC's unique combination of NCE drugs and enabling technologies can improve outcomes for this orphan indication while also addressing the needs of those with presbyopia or suffering from dry-eye syndrome.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
TALLC Corporation has never raised funding before.
TALLC Corporation Tech Stack
Discover the technologies and tools that power TALLC Corporation's digital infrastructure, from frameworks to analytics platforms.
Tag managers
Cookie compliance
Reverse proxies
Web servers
Frequently asked questions
4.8
40,000 users



